Cluster 767: interpretation results safety interfere evaluation condition opinion study investigator patient 
Cluster 1758: risk condition pose investigator unacceptable place study opinion interfere patient 
Cluster 2145: absorption gastrointestinal disorder affecting gastrectomy interfere rucaparib peptic opinion investigator 
Cluster 2161: pose safety risk opinion consulted condition disorder amgen interfere investigator 
